DNMT inhibitor (Zebularine) degrades HIF-1α and overcomes hypoxia-induced Oxaliplatin resistance by upregulating the activity of pyruvate dehydrogenase (PHD) that activated PHD increases the conversion from pyruvate to acetyl CoA for oxidation in CRC mice model [105]. Here, HIF1A is linked to colorectal carcinoma.